As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
We are very excited to launch our new website! Please take a few moments to click around and explore...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...